Comparison of the effectiveness of cyclophosphamide and rituximab treatment in patients with systemic sclerosis–related interstitial lung diseases: a retrospective, observational cohort study

被引:0
作者
Deniz Demir Yılmaz
Sermin Borekci
Benan Musellim
机构
[1] Istanbul University-Cerrahpasa,Department of Pulmonary Diseases, Cerrahpasa Medical Faculty
来源
Clinical Rheumatology | 2021年 / 40卷
关键词
Cyclophosphamide; Rituximab; Systemic sclerosis–related interstitial lung diseases;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:4071 / 4079
页数:8
相关论文
共 50 条
  • [41] Efficacy of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis
    Xinyu Ma
    Rui Tang
    Mei Luo
    Zhuotong Zeng
    Yaqian Shi
    Bingsi Tang
    Rong Xiao
    Clinical Rheumatology, 2021, 40 : 3185 - 3193
  • [42] A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease
    Daoussis, Dimitrios
    Melissaropoulos, Konstantinos
    Sakellaropoulos, Georgios
    Antonopoulos, Ioannis
    Markatseli, Theodora E.
    Simopoulou, Theodora
    Georgiou, Panagiotis
    Andonopoulos, Andrew P.
    Drosos, Alexandros A.
    Sakkas, Lazaros
    Liossis, Stamatis-Nick
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2017, 46 (05) : 625 - 631
  • [43] Prognostic and predictive markers of systemic sclerosis-associated interstitial lung disease in a clinical trial and long-term observational cohort
    Ghuman, Abeer
    Khanna, Dinesh
    Lin, Celia J. F.
    Furst, Daniel E.
    Raghu, Ganesh
    Martinez, Fernando J.
    Zucchetto, Mauro
    Huang, Suiyuan
    Jennings, Angus
    Nihtyanova, Svetlana, I
    Denton, Christopher P.
    RHEUMATOLOGY, 2024, 63 (02) : 472 - 481
  • [44] Mycophenolate Versus Cyclophosphamide for Progressive Interstitial Lung Disease Associated with Systemic Sclerosis: A 2-Year Case Control Study
    Panopoulos, Stylianos T.
    Bournia, Vassiliki-Kalliopi
    Trakada, Georgia
    Giavri, Irene
    Kostopoulos, Charalambos
    Sfikakis, Petros P.
    LUNG, 2013, 191 (05) : 483 - 489
  • [45] Mycophenolate Versus Cyclophosphamide for Progressive Interstitial Lung Disease Associated with Systemic Sclerosis: A 2-Year Case Control Study
    Stylianos T. Panopoulos
    Vassiliki-Kalliopi Bournia
    Georgia Trakada
    Irene Giavri
    Charalambos Kostopoulos
    Petros P. Sfikakis
    Lung, 2013, 191 : 483 - 489
  • [46] Rituximab on lung, skin, and joint involvement in patients with systemic sclerosis: A case series study and review of the literature
    Tugsal, Handan Yarkan
    Zengin, Berrin
    Kenar, Gokce
    Onen, Fatos
    Birlik, Merih
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2022, 25 (07) : 755 - 768
  • [47] Ongoing clinical trials and treatment options for patients with systemic sclerosis-associated interstitial lung disease
    Khanna, Dinesh
    Tashkin, Donald P.
    Denton, Christopher P.
    Lubell, Martin W.
    Vazquez-Mateo, Cristina
    Wax, Stephen
    RHEUMATOLOGY, 2019, 58 (04) : 567 - 579
  • [48] LONG-TERM OUTCOMES OF AFRICAN AMERICAN PATIENTS WITH SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE
    Volkmann, Elizabeth
    Ning, Li
    Khanna, Dinesh
    Clements, Philip
    Furst, Daniel
    Assassi, Shervin
    Roth, Michael
    Elashoff, Robert
    Tashkin, Donald
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1808 - 1808
  • [49] Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study
    Li, Qiang
    Wallace, Laura
    Patnaik, Padmaja
    Alves, Margarida
    Gahlemann, Martina
    Kohlbrenner, Veronika
    Raabe, Christina
    Wang, Jocelyn R.
    Garry, Elizabeth M.
    RHEUMATOLOGY, 2021, 60 (04) : 1915 - 1925
  • [50] Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis:: A retrospective multicenter open-label study
    Berezne, Alice
    Ranque, Brigitte
    Valeyre, Dominique
    Brauner, Michel
    Allanore, Yannick
    Launay, David
    Le Guern, Veronique
    Kahn, Jean-Emmanuel
    Couderc, Louis-Jean
    Constans, Joel
    Cohen, Pascal
    Mahr, Alfred
    Pagnoux, Christian
    Hachulla, Eric
    Kahan, Andre
    Cabane, Jean
    Guillevin, Loic
    Mouthon, Luc
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1064 - 1072